ALIMERA SCIENCES

alimera-sciences-logo

Alimera Sciences is a pharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. They are focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in their aging populations.
#SimilarOrganizations #People #Financial #Website #More

ALIMERA SCIENCES

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical

Founded:
2003-01-01

Address:
Alpharetta, Georgia, United States

Country:
United States

Website Url:
http://www.alimerasciences.com

Total Employee:
51+

Status:
Active

Contact:
+1 678 990 5740

Email Addresses:
[email protected]

Total Funding:
304.35 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.


Current Advisors List

garheng-kong_image

Garheng Kong Board of Directors @ Alimera Sciences
Board_member
2012-10-01

frank-torti_image

Frank Torti Investor @ Alimera Sciences
Board_member

peter-j-pizzo_image

Peter J. Pizzo Board of Directors & Chair, Audit Committee @ Alimera Sciences
Board_member

mark-brooks_image

Mark Brooks Board Member @ Alimera Sciences
Board_member

mary-szela_image

Mary Szela Member of Board @ Alimera Sciences
Board_member
2018-06-01

peter-j-pizzo_image

Peter J. Pizzo Board Member, Chairman of Audit Committee, Member of Corporate Governance and Nominating Committee @ Alimera Sciences
Board_member
2010-04-01

brian-halak_image

Brian Halak Member of Board of Directors @ Alimera Sciences
Board_member

Current Employees Featured

rick-eiswirth_image

Rick Eiswirth
Rick Eiswirth CEO, President & Director @ Alimera Sciences
CEO, President & Director
2005-10-01

ken-greene_image

Ken Greene
Ken Greene Chief Scientific Officer @ Alimera Sciences
Chief Scientific Officer
2004-08-01

philip-ashman_image

Philip Ashman
Philip Ashman Chief Operating Officer, SVP Commercial Operations Europe @ Alimera Sciences
Chief Operating Officer, SVP Commercial Operations Europe
2019-01-01

samer-kaba_image

Samer Kaba
Samer Kaba Chief Medical Officer @ Alimera Sciences
Chief Medical Officer
2019-04-01

dave-holland_image

Dave Holland
Dave Holland Co-Founder, Chief Marketing Officer, SVP Corporate Communications and Managed Markets @ Alimera Sciences
Co-Founder, Chief Marketing Officer, SVP Corporate Communications and Managed Markets
2019-01-01

phil-jones_image

Phil Jones
Phil Jones CFO @ Alimera Sciences
CFO
2019-01-02

bryce-youngren_image

Bryce Youngren
Bryce Youngren Director @ Alimera Sciences
Director

rex-horton_image

Rex Horton
Rex Horton Vice President, Regulatory Affairs, Pharmacovigilance and QA @ Alimera Sciences
Vice President, Regulatory Affairs, Pharmacovigilance and QA
2021-06-01

susan-caballa_image

Susan Caballa
Susan Caballa Sr. Vice President, Regulatory & Medical Affairs @ Alimera Sciences
Sr. Vice President, Regulatory & Medical Affairs

philip-ashman_image

Philip Ashman
Philip Ashman Senior Vice President and European Managing Director @ Alimera Sciences
Senior Vice President and European Managing Director
2013-01-01

Founder


dan-myers_image

Dan Myers

dave-holland_image

Dave Holland

Stock Details


Company's stock symbol is NASDAQ:ALIM

Investors List

ocumension-therapeutics_image

Ocumension Therapeutics

Ocumension Therapeutics investment in Post-IPO Equity - Alimera Sciences

federal-government_image

Federal Government

Federal Government investment in Post-IPO Debt - Alimera Sciences

deerfield_image

Deerfield

Deerfield investment in Post-IPO Equity - Alimera Sciences

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Alimera Sciences

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Post-IPO Equity - Alimera Sciences

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Post-IPO Equity - Alimera Sciences

palo-alto-investors_image

Palo Alto Investors

Palo Alto Investors investment in Post-IPO Equity - Alimera Sciences

domain-associates_image

Domain Associates

Domain Associates investment in Series C - Alimera Sciences

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series C - Alimera Sciences

intersouth-partners_image

Intersouth Partners

Intersouth Partners investment in Series C - Alimera Sciences

Official Site Inspections

http://www.alimerasciences.com Semrush global rank: 4.97 M Semrush visits lastest month: 1.71 K

  • Host name: cloudhost-63201.uk-south-2.nxcli.net
  • IP address: 165.84.219.3
  • Location: Byfleet United Kingdom
  • Latitude: 51.3388
  • Longitude: -0.474
  • Timezone: Europe/London
  • Postal: KT14

Loading ...

More informations about "Alimera Sciences" on Search Engine

dfkcompany.com © 2022. All rights reserved